Literature DB >> 10205769

Quantitative structure-pharmacokinetics relationships: II. A mechanistically based model to evaluate the relationship between tissue distribution parameters and compound lipophilicity.

I Nestorov1, L Aarons, M Rowland.   

Abstract

The tissue-to-unbound plasma distribution coefficients (Kpus) of 14 rat tissues after i.v. administration of nine 5-n-alkyl-5-ethyl barbituric acids, determined in a previous study, were used to identify a model of the relationship between tissue distribution and lipophilicity of the homologs, expressed in terms of their octanol to water partition ratio, P. Based on mechanistic considerations and assumptions, the parameter model was expressed as Kpu tau = fw.tau [1 + a tau (nPt.tau)Pb tau], where fw.tau is the tissue water content. (nPt. tau) is the binding capacity of the tissue, n is the number of the binding sites, a tau and b tau are the parameters of the relationship Ka tau = a tau Pb tau; and Ka tau is the binding association constant of each tissue. The parameter model was linearized and fitted to the predetermined Kpu values, yielding correlation coefficients ranging between .940 and .997. The predictive performance of the parameter model was evaluated using a leave-one-out procedure with subsequent computation of the mean prediction error (ME = measurement of the prediction bias) and the square root of the mean squared prediction error (RMSE = measurement of the prediction accuracy). The ME varied between -22.48 and 61.14%, indicating a slight tendency for overpredicting. The RMSE was between 24.73 and 102% for the individual tissues across the different homologs; and between 28.33 and 85.2% for the individual homologs across the different tissues. The apparently high Kpu prediction errors, when translated through the low sensitivity of the barbiturate whole-body physiologically based pharmacokinetic model, established previously, leads to predicted tissue concentration-time profiles within 5 to 20% of the original ones. Therefore, it is concluded, that the identified mechanistically based model is a good predictor of the tissue-to-unbound Kpus in the rat tissues.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10205769     DOI: 10.1023/a:1023221116200

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  22 in total

1.  A semiparametric approach to physiological flow models.

Authors:  D Verotta; L B Sheiner; W F Ebling; D R Stanski
Journal:  J Pharmacokinet Biopharm       Date:  1989-08

Review 2.  Using structural information to create physiologically based pharmacokinetic models for all polychlorinated biphenyls.

Authors:  F M Parham; M C Kohn; H B Matthews; C DeRosa; C J Portier
Journal:  Toxicol Appl Pharmacol       Date:  1997-06       Impact factor: 4.219

3.  Solubility and partitioning. VII: Solubility of barbiturates in water.

Authors:  R Pinal; S H Yalkowsky
Journal:  J Pharm Sci       Date:  1987-01       Impact factor: 3.534

4.  Thiopental pharmacokinetics.

Authors:  K B Bischoff; R L Dedrick
Journal:  J Pharm Sci       Date:  1968-08       Impact factor: 3.534

5.  Relationships between the hepatic intrinsic clearance or blood cell-plasma partition coefficient in the rabbit and the lipophilicity of basic drugs.

Authors:  J Ishizaki; K Yokogawa; E Nakashima; F Ichimura
Journal:  J Pharm Pharmacol       Date:  1997-08       Impact factor: 3.765

6.  Kinetics of distribution and adipose tissue storage as a function of lipophilicity and chemical structure. I. Barbiturates.

Authors:  S H Steiner; M J Moor; M H Bickel
Journal:  Drug Metab Dispos       Date:  1991 Jan-Feb       Impact factor: 3.922

7.  Some suggestions for measuring predictive performance.

Authors:  L B Sheiner; S L Beal
Journal:  J Pharmacokinet Biopharm       Date:  1981-08

8.  Tissue water content in rats measured by desiccation.

Authors:  R F Reinoso; B A Telfer; M Rowland
Journal:  J Pharmacol Toxicol Methods       Date:  1997-10       Impact factor: 1.950

9.  An approach for incorporating tissue composition data into physiologically based pharmacokinetic models.

Authors:  M Pelekis; P Poulin; K Krishnan
Journal:  Toxicol Ind Health       Date:  1995 Sep-Oct       Impact factor: 2.273

10.  Structure-pharmacokinetic relationships among the barbiturates in the rat.

Authors:  S Toon; M Rowland
Journal:  J Pharmacol Exp Ther       Date:  1983-06       Impact factor: 4.030

View more
  6 in total

1.  Prediction of in vivo tissue distribution from in vitro data. 3. Correlation between in vitro and in vivo tissue distribution of a homologous series of nine 5-n-alkyl-5-ethyl barbituric acids.

Authors:  Peter Ballard; David E Leahy; Malcolm Rowland
Journal:  Pharm Res       Date:  2003-06       Impact factor: 4.200

Review 2.  Whole body pharmacokinetic models.

Authors:  Ivan Nestorov
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 3.  Physiologically-based pharmacokinetic modeling for absorption, transport, metabolism and excretion.

Authors:  K Sandy Pang; Matthew R Durk
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-12-14       Impact factor: 2.745

4.  Empirical versus mechanistic modelling: comparison of an artificial neural network to a mechanistically based model for quantitative structure pharmacokinetic relationships of a homologous series of barbiturates.

Authors:  I S Nestorov; S T Hadjitodorov; I Petrov; M Rowland
Journal:  AAPS PharmSci       Date:  1999

5.  PBPK Modeling to Simulate the Fate of Compounds in Living Organisms.

Authors:  Frédéric Y Bois; Cleo Tebby; Céline Brochot
Journal:  Methods Mol Biol       Date:  2022

Review 6.  Drug structure-transport relationships.

Authors:  Michael S Roberts
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-11-24       Impact factor: 2.745

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.